- Correspondence
- Open access
- Published:
Prevalence and impact of Eustachian valve on the diagnosis of patent foramen ovale in patients ventilated for an acute respiratory distress syndrome
Critical Care volume 27, Article number: 392 (2023)
Elective increase of right atrial (RA) pressure may contribute to reopening a patent foramen ovale (PFO) by reversing normal interatrial pressure gradient [1]. Accordingly, PFO is identified in 15 to 19% of patients ventilated for an acute respiratory distress syndrome (ARDS) due to increased right ventricular afterload [1, 2]. PFO diagnosis relies on transesophageal echocardiography (TEE) coupled with a contrast study. Eustachian valve, a remnant of the right sinus venosus valve located at the junction between the inferior vena cava (IVC) and RA, may hamper the identification of a PFO. We sought to assess the prevalence of persistent Eustachian valve and its impact on PFO depiction in ventilated adult ARDS patients.
This ancillary study included the subset of patients hospitalized in our ICU who previously participated in the multicenter ARCOFOP study [2]. The selection of this cohort was based on the availability of digitally stored TEE loops for off-line analysis. We studied 79 ARDS patients [median age: 58 (25th–75th percentiles: 47–68) years; 59 men; SAPSII: 43 (32–53); SOFA: 7 (4–10); PaO2/FiO2: 95 (72–138)] under protective mechanical ventilation [tidal volume: 6.2 (5.8–7.0) ml/kg; PEEP: 10 (8–12) cmH2O; plateau pressure: 25 (24–27) cmH2O] for moderate-to-severe ARDS unrelated to SARS-CoV-2. Data analysis was restricted to the interpretation of TEE contrast studies (20 mL of agitated saline injected through the central venous catheter located in the superior vena cava) in the longitudinal view of the interatrial septum (bicaval view). RA opacification was deemed complete when microbubbles enhanced its entire surface and reached the fossa ovalis for a least three cardiac cycles. PFO was diagnosed when microbubbles entered the left atrium through the foramen ovale during the first three cardiac cycles following full RA opacification, and right-to-left interatrial shunt was assessed semiquantitatively using a previously proposed 3-grade scale [3]. The presence of Eustachian valve and its length was systematically assessed.
Eustachian valve was identified in 19 patients (24%) and its median length reached 15 [11.5–16.5] mm. PFO was identified in 19 patients (24%), with mild-to-moderate right-to-left shunt (grade 1: n = 13; grade 2: n = 6 patients; grade 3: n = 0). RA opacification was incomplete in 13 patients (16%), 12 of them having Eustachian valve. Incomplete RA opacification was more frequent in patients with Eustachian valve than in their counterparts (12/19 (63%) versus 1/60 (2%): p < 0.001), whereas PFO prevalence was similar (5/19 (26%) versus 14/60 (23%): p = 0.767). In 3 patients with incomplete RA opacification due to Eustachian valve, injection of microbubbles through the IVC (femoral vein) enabled complete RA opacification and PFO identification in 2 of them with a grade 2 interatrial shunt (Fig. 1).
Eustachian valve was identified in one-fourth of our patients under protective ventilation for a moderate-to-severe ARDS and was not associated with a higher prevalence of PFO. The 24% prevalence of PFO in our cohort was similar to that reported previously in patients with similar characteristics [1] and to the 27% incidence reported in a large necropsy study performed in the general population [4]. Actual prevalence of PFO may have been underestimated since RA opacification was incomplete in 16% of our patients and may have led to false-negative results of contrast studies. During fetal development, the Eustachian valve directs oxygenated blood flow from the IVC toward the foramen ovale and the systemic circulation through the left atrium. Usually, it involutes during the first years of life. Its persistence in adulthood can prevent spontaneous closing of PFO by directing blood from the IVC directly toward the interatrial septum. Consequently, it can lead to false-negative results of TEE contrast study in precluding the microbubbles injected through the superior vena cava to reach the interatrial septum, as in 12/13 of our patients with incomplete RA opacification. Although Gin et al. [5] recommended injecting the microbubbles through the femoral vein to increase the sensitivity of echocardiography contrast study for the detection of PFO, they did not report on the presence of Eustachian valve. Interestingly, 2 of our 3 patients with a negative TEE contrast study who underwent an additional injection of microbubbles through the IVC (femoral vein) exhibited a PFO with a grade 2 interatrial shunt, which was not initially identified. In contrast, the presence of a negative conventional TEE contrast study with full RA opacification allows to confidently rule out PFO [3]. The present study is limited by its retrospective design and by the lack of systematic injection of microbubbles through the IVC in patients with incomplete RA opacification, which precluded determining the actual proportion of false-negative TEE contrast study.
Eustachian valve was present in one-fourth of our patients ventilated for a moderate-to-severe ARDS unrelated to SARS-CoV-2 and was closely associated with incomplete RA opacification during TEE contrast study. In patients with Eustachian valve and incomplete RA opacification, an additional injection of microbubbles through the IVC should be performed to avoid false-negative results.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- RA:
-
Right atrium
- ARDS:
-
Acute respiratory distress syndrome
- PFO:
-
Patent foramen ovale
- TEE:
-
Transesophageal echocardiography
- IVC:
-
Inferior vena cava
References
Mekontso Dessap A, Boissier F, Leon R, Carreira S, Campo FR, Lemaire F, Brochard L. Prevalence and prognosis of shunting across patent foramen ovale during acute respiratory distress syndrome. Crit Care Med. 2010;38:1786–92. https://0-doi-org.brum.beds.ac.uk/10.1097/CCM.0b013e3181eaa9c8.
Lhéritier G, Legras A, Caille A, Lherm T, Mathonnet A, Frat JP, Courte A, Martin-Lefèvre L, Gouëllo JP, Amiel JB, Garot D, Vignon P. Prevalence and prognostic value of acute cor pulmonale and patent foramen ovale in ventilated patients with early acute respiratory distress syndrome: a multicenter study. Intensive Care Med. 2013;39:1734–42. https://0-doi-org.brum.beds.ac.uk/10.1007/s00134-013-3017-6.
Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol. 1996;77:1202–9. https://0-doi-org.brum.beds.ac.uk/10.1016/s0002-9149(96)00163-4.
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20. https://0-doi-org.brum.beds.ac.uk/10.1016/s0025-6196(12)60336-x.
Gin KG, Huckell VF, Pollick C. Femoral vein delivery of contrast medium enhances transthoracic echocardiographic detection of patent foramen ovale. J Am Coll Cardiol. 1993;22:1994–2000. https://0-doi-org.brum.beds.ac.uk/10.1016/0735-1097(93)90789-4.
Acknowledgements
None.
Funding
None.
Author information
Authors and Affiliations
Contributions
Florence Sanchez and Philippe Vignon designed the study and drafted the manuscript, Marine Goudelin and Bruno Evrard performed data analysis and constructively reviewed the manuscript. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The present study is an ancillary analysis of a previously published observational study (ARCOFOP) approved by the Ethics Committee of the Société de Réanimation de Langue Française, which waived the need for informed consent.
Consent for publication
NA.
Competing interests
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Sanchez, F., Goudelin, M., Evrard, B. et al. Prevalence and impact of Eustachian valve on the diagnosis of patent foramen ovale in patients ventilated for an acute respiratory distress syndrome. Crit Care 27, 392 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s13054-023-04670-9
Received:
Accepted:
Published:
DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13054-023-04670-9